With regards to the Cap raising, it doesn't look like the whole lot is there on the CF statement.
Proceeds from issues of shares etc is listed at $12M - its like its just the institutional part of the cap raise. Can anyone clarify this? If this is the case, the cash position will be bolstered further and there won't be a need for a cap raise quite so soon.
- Forums
- ASX - By Stock
- AVR
- Quarterly
Quarterly, page-12
-
- There are more pages in this discussion • 163 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVR (ASX) to my watchlist
|
|||||
Last
$17.79 |
Change
-0.120(0.67%) |
Mkt cap ! $347.9M |
Open | High | Low | Value | Volume |
$18.00 | $18.10 | $17.79 | $30.95K | 1.724K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 26 | $17.72 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$17.93 | 786 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 26 | 17.720 |
1 | 586 | 17.710 |
1 | 443 | 17.700 |
2 | 276 | 17.650 |
1 | 200 | 17.560 |
Price($) | Vol. | No. |
---|---|---|
17.930 | 786 | 4 |
17.940 | 42 | 2 |
18.000 | 312 | 2 |
18.140 | 45 | 1 |
18.240 | 500 | 1 |
Last trade - 11.28am 16/07/2024 (20 minute delay) ? |
Featured News
AVR (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online